Malaria elimination in Africa: Rethinking strategies for 'Plasmodium vivax' and lessons from Botswana

The global malaria community has picked up the theme of malaria elimination in more than 90% of the world's population in the next decade. Recent reports of 'Plasmodium vivax' ('P. vivax') in sub-Saharan Africa, including in Duffy-negative individuals, threaten the efforts aimed at achieving elimination. This is not only in view of strategies that are tailored only to 'P. falciparum' elimination but also due to currently revealed biological characteristics of 'P. vivax' concerning the relapse patterns of hypnozoites and conservation of large biomasses in cryptic sites in the bone marrow and spleen. A typical scenario was observed in Botswana between 2008 and 2018, which palpably projects how 'P. vivax' could endanger malaria elimination efforts where the two parasites co-exist. The need for the global malaria community, national malaria programs (NMPs), funding agencies and relevant stakeholders to engage in a forum to discuss and recommend clear pathways for elimination of malaria, including 'P. vivax', in sub-Saharan Africa is warranted.